Panamor-25 25 mg FC tablets
PDF Leaflet Revision Date: 29 November 2021
Clinical Summary
Quick overview from the medicine insert
Indication
For treatment of fever or mild to moderate pain of inflammatory origin.
Dosage (summary)
Adults: 1 tablet three times daily, max 75 mg/day for 5 days.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Avoid in pregnancy from 20 weeks; not recommended during breastfeeding.
Key Drug Interactions
- Anticoagulants
- Other NSAIDs
- Diuretics
- Methotrexate
Contraindications
- Hypersensitivity to diclofenac
- Active gastrointestinal bleeding
- Porphyria
- Children under 2 years
Common side effects
- Gastrointestinal bleeding
- Nausea
- Headache
- Dizziness
Counselling Points
- Take with water
- Report unusual abdominal symptoms
- Avoid alcohol
Serious warnings
- Risk of cardiovascular events
- Gastrointestinal ulceration
- Serious allergic reactions
Important Disclaimer
The Panamor-25 25 mg FC tablets professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
